FDA Approves Skinvive by Juvéderm

FDA Approves Skinvive by Juvéderm

FDA Approves Skinvive by Juvéderm (hyaluronic acid) Microdroplet Injection to Improve Skin Smoothness of the Cheeks IRVINE, Calif., May 15, 2023 /PRNewswire/ — Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of Skinvive™ by Juvéderm®…

Read More